Effects of puerarin on the pharmacokinetics of triptolide in rats
Context: Puerarin and triptolide are sometimes used together for the treatment of disease in Chinese clinics; however, the drug–drug interaction between puerarin and triptolide is still unknown. Objective: This study investigates the effects of puerarin on the pharmacokinetics of triptolide in rats...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e5f3d490926b42039ec13101186d9bf0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e5f3d490926b42039ec13101186d9bf0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e5f3d490926b42039ec13101186d9bf02021-11-17T14:21:56ZEffects of puerarin on the pharmacokinetics of triptolide in rats1388-02091744-511610.1080/13880209.2019.1626448https://doaj.org/article/e5f3d490926b42039ec13101186d9bf02019-01-01T00:00:00Zhttp://dx.doi.org/10.1080/13880209.2019.1626448https://doaj.org/toc/1388-0209https://doaj.org/toc/1744-5116Context: Puerarin and triptolide are sometimes used together for the treatment of disease in Chinese clinics; however, the drug–drug interaction between puerarin and triptolide is still unknown. Objective: This study investigates the effects of puerarin on the pharmacokinetics of triptolide in rats and clarifies its main mechanism. Materials and methods: The pharmacokinetic profiles of oral administration of triptolide (1 mg/kg) in Sprague-Dawley rats with (test group, n = 6) or without pretreatment (control group, n = 6) with puerarin (100 mg/kg/day for seven days) were investigated. The effects of puerarin on the transport and metabolic stability of triptolide were also investigated using Caco-2 cell transwell model and rat liver microsomes. Results: The results showed that puerarin could significantly increase the peak plasma concentration (from 187.25 ± 15.36 to 219.67 ± 21.52 ng/mL), and decrease its oral clearance (from 4.92 ± 0.35 to 62.46 ± 3.75 ± 0.19 L/h/kg). The Caco-2 cell transwell experiments indicated that puerarin could decrease the efflux ratio of triptolide from 2.70 to 1.33, and the intrinsic clearance rate of triptolide was decreased by the pretreatment with puerarin (38.8 ± 4.7 vs. 32.9 ± 6.5 μL/min/mg protein). Discussion and conclusions: Puerarin could significantly change the pharmacokinetic profiles of triptolide in rats, and it might exert these effects through increasing the absorption of triptolide by inhibiting the activity of P-gp, or through inhibiting the metabolism of triptolide in rat liver. The results also showed that the dose of triptolide should be decreased when these drugs were co-administered.Qingfa WangYanping WuFengting XiangYan FengZhenghao LiYufeng DingTaylor & Francis Grouparticlecaco-2 cellsp-gpmetabolismTherapeutics. PharmacologyRM1-950ENPharmaceutical Biology, Vol 57, Iss 1, Pp 407-411 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
caco-2 cells p-gp metabolism Therapeutics. Pharmacology RM1-950 |
spellingShingle |
caco-2 cells p-gp metabolism Therapeutics. Pharmacology RM1-950 Qingfa Wang Yanping Wu Fengting Xiang Yan Feng Zhenghao Li Yufeng Ding Effects of puerarin on the pharmacokinetics of triptolide in rats |
description |
Context: Puerarin and triptolide are sometimes used together for the treatment of disease in Chinese clinics; however, the drug–drug interaction between puerarin and triptolide is still unknown. Objective: This study investigates the effects of puerarin on the pharmacokinetics of triptolide in rats and clarifies its main mechanism. Materials and methods: The pharmacokinetic profiles of oral administration of triptolide (1 mg/kg) in Sprague-Dawley rats with (test group, n = 6) or without pretreatment (control group, n = 6) with puerarin (100 mg/kg/day for seven days) were investigated. The effects of puerarin on the transport and metabolic stability of triptolide were also investigated using Caco-2 cell transwell model and rat liver microsomes. Results: The results showed that puerarin could significantly increase the peak plasma concentration (from 187.25 ± 15.36 to 219.67 ± 21.52 ng/mL), and decrease its oral clearance (from 4.92 ± 0.35 to 62.46 ± 3.75 ± 0.19 L/h/kg). The Caco-2 cell transwell experiments indicated that puerarin could decrease the efflux ratio of triptolide from 2.70 to 1.33, and the intrinsic clearance rate of triptolide was decreased by the pretreatment with puerarin (38.8 ± 4.7 vs. 32.9 ± 6.5 μL/min/mg protein). Discussion and conclusions: Puerarin could significantly change the pharmacokinetic profiles of triptolide in rats, and it might exert these effects through increasing the absorption of triptolide by inhibiting the activity of P-gp, or through inhibiting the metabolism of triptolide in rat liver. The results also showed that the dose of triptolide should be decreased when these drugs were co-administered. |
format |
article |
author |
Qingfa Wang Yanping Wu Fengting Xiang Yan Feng Zhenghao Li Yufeng Ding |
author_facet |
Qingfa Wang Yanping Wu Fengting Xiang Yan Feng Zhenghao Li Yufeng Ding |
author_sort |
Qingfa Wang |
title |
Effects of puerarin on the pharmacokinetics of triptolide in rats |
title_short |
Effects of puerarin on the pharmacokinetics of triptolide in rats |
title_full |
Effects of puerarin on the pharmacokinetics of triptolide in rats |
title_fullStr |
Effects of puerarin on the pharmacokinetics of triptolide in rats |
title_full_unstemmed |
Effects of puerarin on the pharmacokinetics of triptolide in rats |
title_sort |
effects of puerarin on the pharmacokinetics of triptolide in rats |
publisher |
Taylor & Francis Group |
publishDate |
2019 |
url |
https://doaj.org/article/e5f3d490926b42039ec13101186d9bf0 |
work_keys_str_mv |
AT qingfawang effectsofpuerarinonthepharmacokineticsoftriptolideinrats AT yanpingwu effectsofpuerarinonthepharmacokineticsoftriptolideinrats AT fengtingxiang effectsofpuerarinonthepharmacokineticsoftriptolideinrats AT yanfeng effectsofpuerarinonthepharmacokineticsoftriptolideinrats AT zhenghaoli effectsofpuerarinonthepharmacokineticsoftriptolideinrats AT yufengding effectsofpuerarinonthepharmacokineticsoftriptolideinrats |
_version_ |
1718425516963266560 |